Elevated neutrophil extracellular traps as potential diagnostic biomarkers in pancreatic ductal adenocarcinoma
Authors:
- 14 July 2026
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 427, 105131
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research (DDR/IIRPSG-2025-01/03487/SG-06)
- Department of Biotechnology, Ministry of Science and Technology, India (DBTHRDPMU/JRF/BET-21/I/2011\u201322/251)
This publication has 49 references indexed in Scilit:
- Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness‐Death Modeling StudyCancer Medicine, 2024
- NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular trapsCancer Cell, 2023
- Levels of tumor markers CEA/CA 19–9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancerAnnals of Gastroenterological Surgery, 2022
- Neutrophil extracellular traps enriched with IL-1β and IL-17A participate in the hepatic inflammatory process of patients with non-alcoholic steatohepatitisVirchows Archiv, 2022
- Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective StudyJournal of Gastrointestinal Cancer, 2021
- Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenalBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2020
- Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2–dependent angiogenesis in miceHepatology, 2017
- Flow cytometric assay for direct quantification of neutrophil extracellular traps in blood samplesAmerican Journal of Hematology, 2015
- Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysisTumor Biology, 2014
- Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03European Journal of Cancer, 2009